- All treatments and products mentioned require a medical prescription and are subject to Invima sanitary registration. Consult a medical specialist before starting any service, treatment and or therapy.
- TRT Colombia S.A.S. are not Doctors, Pharmacies, Nurses, Clinics or Medical Experts. We are marketing brokers who connect our clients to professional, licensed medical professionals in the country of Colombia. We do not provide professional medical advice. Consult a medical specialist before starting any therapy or product. Please refer to our disclaimer page for the complete information.
If you’ve been researching peptide therapy options for body composition, you’ve likely come across tesamorelin more than once. Tesamorelin is a growth hormone-releasing hormone analog that has drawn attention for its documented ability to reduce visceral fat, the deep fat in the stomach area linked to metabolic risk, and it has been studied in clinical trials for that specific purpose within peptide therapy. This guide covers what tesamorelin is, how it works, what the research shows, and what a physician-guided tesamorelin treatment plan through TRT Colombia looks like for clients who are candidates.
What Is Tesamorelin?
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, meaning it mimics the natural growth hormone releasing hormone your body already produces. In plain terms, it’s a peptide that signals your pituitary gland to release more of your body’s own growth hormone, rather than introducing growth hormone directly. Tesamorelin injection was originally developed and FDA-approved for a specific patient population, and its effects on visceral fat have since made it one of the more closely studied peptides in body composition research and in the broader peptide therapy field.
Within peptide therapy generally, tesamorelin stands out because its outcomes are backed by FDA-reviewed clinical trials rather than only anecdotal reports, which gives clients researching peptide therapy options something firmer to discuss with their doctor.
Because tesamorelin works upstream, by prompting your pituitary gland to produce more growth hormone rather than replacing it, it acts on your body’s own pattern of growth hormone release instead of adding growth hormone from outside. That distinction matters both physiologically and when a licensed doctor is deciding whether tesamorelin is an appropriate fit for a given client.
How Tesamorelin Works On Growth Hormone
Growth hormone (GH) secretion happens in pulses throughout the day, and that pulsing pattern tends to decline with age. Tesamorelin binds to GHRH receptors in the pituitary gland, which increases the amplitude of each natural GH pulse. That, in turn, raises insulin-like growth factor 1, or IGF-1, a hormone closely tied to how the body regulates fat metabolism, tissue repair, and lean mass.
The reason tesamorelin has such a specific effect on visceral fat, rather than fat throughout the body generally, has to do with how visceral adipose tissue responds to GH signaling. Visceral fat, the fat that surrounds abdominal organs, appears to respond more to growth hormone and IGF-1 signaling than subcutaneous fat does, which is part of why tesamorelin’s clinical effects concentrate there rather than producing generalized fat loss.
Tesamorelin And Visceral Fat: What The Research Shows
Tesamorelin results for visceral fat are among the better-documented outcomes in the peptide space, largely because the drug went through the FDA approval process, which requires randomized controlled trials. In one randomized trial of antiretroviral-treated patients with abdominal fat accumulation, tesamorelin reduced visceral adipose tissue by an average of about 34 square centimeters over six months, compared with a slight increase in the placebo group, for a net treatment effect of about 42 square centimeters, according to the published trial results. The same trial also found modest reductions in liver fat, and the researchers noted that further studies are needed to determine the clinical importance of these findings.
These are the kinds of outcomes a licensed doctor will discuss with you directly, since individual results vary and depend on your starting point, your overall health, and how your body responds to treatment. Tesamorelin is not a guaranteed fat-loss outcome for any individual client, and no reputable provider should present it that way.
Beyond visceral fat and liver fat, some of the broader clinical trials on tesamorelin have also looked at markers like insulin sensitivity and lean muscle preservation, since a treatment that reduced excess fat but also reduced lean muscle would be a very different clinical picture than one that helps preserve lean muscle while reducing excess fat. If you are considering tesamorelin, discuss with your physician which of these outcomes matter most for your specific goals.
Who Tesamorelin Was Originally Developed For
Tesamorelin was approved by the FDA specifically to treat HIV-associated lipodystrophy. In this condition, antiretroviral therapy for human immunodeficiency virus contributes to abnormal body fat redistribution, including excess visceral fat concentrated in the abdominal area. Some patients notice changes to the skin and soft tissue of the face and limbs, with thinning skin and fat loss in some areas alongside fat accumulation in the abdominal area. MedlinePlus drug information confirms tesamorelin treats this excess abdominal fat in HIV-positive adults and is specifically not indicated for general weight loss. Tesamorelin’s approval is narrow and specific, even though its underlying mechanism, reducing visceral fat through growth hormone signaling, has since drawn interest well beyond that original patient population.
Because HIV-associated lipodystrophy can also involve liver changes, some of the same patients who benefit from visceral fat reduction have also been studied for related outcomes such as nonalcoholic fatty liver disease markers, which is part of why the liver fat findings mentioned above drew research interest beyond the primary visceral fat outcome.
Beyond HIV-Associated Lipodystrophy: Broader Interest Under Physician Judgment
Because tesamorelin’s visceral-fat-reducing mechanism isn’t unique to HIV-associated lipodystrophy, clinicians and researchers have taken a broader interest in how it might support body composition and metabolic health in other patients, always under individualized physician judgment rather than as a self-directed treatment. This is an area where the research base is still developing outside the original approved indication, which is exactly why a proper medical evaluation matters before any client considers tesamorelin, and why that decision always stays with a licensed physician.
A licensed doctor considering tesamorelin for any client will weigh the client’s health history, current metabolic markers, and realistic goals before recommending it, and will monitor the client closely once treatment begins. This is not a peptide that should be pursued through self-sourcing or without that kind of oversight, given the metabolic effects involved.
What To Expect From Tesamorelin Treatment

In a physician-guided treatment plan, your prescribing doctor decides how tesamorelin is given, along with your dose, schedule, and treatment duration, based on your evaluation and not a generic protocol. Your doctor will also set a follow-up and monitoring schedule, since tracking markers like IGF-1 and blood sugar over time is part of responsible tesamorelin treatment.
Your prescribing physician will see you periodically to review how your body is responding, adjust the dose if needed, and confirm the treatment is still appropriate to continue.
Dose decisions are not one-size-fits-all. A prescribing physician sets the starting dose based on a client’s lab work, health history, and treatment goals, and may adjust that dose over the course of treatment depending on how a client responds. Never adjust your own dose or extend a course of treatment without your physician’s direction. Dose changes are a clinical decision that depends on ongoing monitoring, not something you should manage alone.
If a client misses a dose, the right move is to contact their prescribing physician rather than guess at how to adjust the next dose on their own. A physician can advise whether to take the missed dose, skip it, or resume the regular dosing schedule, and that guidance depends on how much time has passed and the client’s specific treatment plan. Clients on a longer course of tesamorelin should also expect their dose to be reviewed periodically rather than left unchanged indefinitely, since ongoing dose review is part of what keeps a physician-guided program safe.
Injection site care matters with any injectable treatment. Your doctor or nurse will explain how injection sites are rotated to reduce skin irritation, since repeated injections in the same small area of skin can lead to local irritation over time. You will also be told what a normal injection site reaction looks like, such as mild redness that settles on its own, compared to a reaction that should be reported to your doctor.
Who Is A Reasonable Candidate For Tesamorelin?
A reasonable candidate for tesamorelin is a qualified client who has been evaluated by a licensed physician, has realistic expectations about what the treatment can and cannot do, and doesn’t have any of the contraindications discussed below. Clients considering tesamorelin for visceral fat support should come to that evaluation with their full health history and current lab work so their physician can make an informed recommendation.
Clients who are pregnant, have active cancer, or have uncontrolled diabetes are generally not candidates for tesamorelin. Diabetes and blood sugar regulation are directly affected by the growth hormone releasing hormone pathway tesamorelin works through. A history of a pituitary gland tumor or other pituitary issues needs extra scrutiny before starting treatment. Clients with a history of stomach surgery, or who are taking prescription or over the counter medications that could interact with tesamorelin, should also flag this during their evaluation, since drug interactions and surgical history can both affect whether tesamorelin is appropriate. This is why self-sourcing tesamorelin carries real risk. Without a physician reviewing your individual risk factors first, warning signs that would rule you out, or call for a modified approach, can be missed entirely.
Possible Side Effects, Drug Interactions, And Who Should Avoid Tesamorelin
Like any prescription treatment, tesamorelin injection carries a list of possible side effects clients should understand before starting. Commonly reported effects include injection site reactions on the skin, joint and muscle pain, and swelling, while more serious effects that warrant contacting your doctor immediately include allergic reactions such as rash or hives, and symptoms of elevated blood sugar, such as increased thirst or urination. Fluid retention is another possible effect, along with tingling or numbness in the hands or feet.
Tesamorelin injection isn’t appropriate for every client. People with active cancer, disruptions to the pituitary gland or hypothalamic-pituitary axis, or uncontrolled diabetes are generally not candidates, and anyone considering tesamorelin should disclose their full medical history, including any history of a pituitary gland tumor, recent stomach surgery, pregnancy, or any unusual or allergic reaction to medicines, to their evaluating physician before starting treatment. Clients should also disclose all other medications and dietary supplements they’re taking, since possible drug interactions, including with corticosteroids or certain HIV medications, may mean your physician needs to adjust those medicines.
Because tesamorelin affects growth hormone and IGF-1 levels, it can also affect blood sugar regulation in some clients, which is why ongoing lab monitoring is part of a responsible treatment plan, particularly for clients who already have risk factors for diabetes, prediabetes, or insulin resistance. Clients with existing diabetes should discuss glucose monitoring frequency with their doctor before starting, since the growth hormone releasing pathway tesamorelin activates can shift blood sugar levels enough to warrant closer attention in that population. A physician who monitors these markers can catch a shift in blood sugar early, before it becomes a meaningful risk.
Why Consider Tesamorelin Peptide Therapy Through TRT Colombia
TRT Colombia connects international clients with licensed doctor allies across six Colombian cities, including Medellín, Bogotá, Cartagena, Barranquilla, Santa Marta, and Cali, who can evaluate whether tesamorelin is an appropriate option as part of a broader, individualized treatment plan. For clients who want access to HGH peptide therapy options like tesamorelin without the friction of arranging care in an unfamiliar healthcare system on their own, working with a coordinated network of experienced providers can simplify that process considerably.
TRT Colombia’s role is coordination, not diagnosis or prescribing. Every step, from your initial evaluation to ongoing monitoring, is handled by a licensed physician, with TRT Colombia’s team supporting logistics like scheduling and communication throughout your treatment. For a wider look at peptide options, see our overview of peptides used for men, or use our glossary of hormone therapy terms for any unfamiliar words. This article goes deeper on tesamorelin specifically.
Safety And When To Consult A Doctor

Tesamorelin’s documented effects on visceral fat make it a serious option for the right client, but it is not the right fit for everyone. A proper evaluation looks at your health history, your current metabolic markers, and your goals, and a licensed doctor is the only person qualified to determine whether tesamorelin fits your situation.
No reputable provider should promise a guaranteed outcome or skip the evaluation step. If you’re considering tesamorelin, treat that evaluation as the actual first step, not a formality after you’ve already decided.
Tell your doctor immediately if you notice signs of allergic reactions after an injection, such as a rash spreading beyond the injection site or hives, and treat any sign of one as a same-day call rather than something to monitor overnight. Swelling of the skin around your face or throat, or trouble breathing, needs emergency medical attention right away. Fluid retention that seems to be getting worse, rather than settling down, is also worth flagging at your next follow-up rather than waiting it out on your own. Clients who are pregnant, or who become pregnant while on tesamorelin, should contact their doctor right away, since tesamorelin should not be used during pregnancy.
Frequently Asked Questions
Is Tesamorelin Similar To Ozempic?
Not in mechanism. Ozempic is a GLP-1 receptor agonist that affects appetite and blood sugar regulation, while tesamorelin works through the growth hormone pathway to specifically target visceral fat. They’re both used in conversations about body composition, but they work through entirely different biological systems, and a licensed doctor can help you understand which, if either, fits your situation.
Will Tesamorelin Get Rid Of Belly Fat?
Tesamorelin has documented effects on visceral fat specifically, the deeper fat in the stomach area around your organs, rather than subcutaneous belly fat you can pinch. Results vary by client, and tesamorelin isn’t a substitute for diet, exercise, or other lifestyle factors that also affect body composition. Your prescribing physician can set realistic expectations based on your specific case.
Is Tesamorelin FDA-Approved?
Yes, tesamorelin injection is FDA-approved specifically for reducing excess abdominal fat in adults with HIV lipodystrophy. Its use for broader body-composition goals outside that specific indication is a medical decision for a licensed physician after individual evaluation, not something the approval itself covers.
How Long Does It Take To See Results From Tesamorelin?
In clinical studies, meaningful changes in visceral fat have been observed over a period of months rather than weeks. Individual timelines vary, and your prescribing doctor will set expectations and monitor your progress at regular intervals rather than promising a fixed timeline.
What Labs Or Monitoring Does Tesamorelin Require?
Physicians typically monitor IGF-1 levels, blood sugar, and other relevant markers throughout treatment, along with periodically reassessing whether the current dose and treatment plan still make sense for that client. The exact monitoring schedule depends on your individual risk factors and how your body responds, which your prescribing physician will determine as part of your treatment plan.
Does Tesamorelin Cause Inflammation?
Mild, localized inflammation at the injection site, redness, warmth, or slight swelling, is a normal and common response and usually settles on its own. Persistent or worsening inflammation, or inflammation that spreads beyond the injection site, should be reported to your prescribing doctor rather than managed on your own.
What Is A Typical Starting Dose Of Tesamorelin?
There isn’t a universal starting dose that applies to every client. Your prescribing physician determines your starting dose, and any dose adjustments that follow, based on your evaluation, lab work, and how you respond to treatment, which is why dose decisions should always come from your doctor rather than a general guideline.
Can Women Use Tesamorelin?
Tesamorelin’s FDA approval is not restricted by sex, and the clinical trials behind it included both men and women. A physician will still evaluate each client’s individual health history, including pregnancy status, before recommending treatment. Anyone who is pregnant or breastfeeding should discuss this directly with their doctor, since tesamorelin isn’t appropriate during pregnancy.
Ready To Learn More?
Tesamorelin is one of the more clinically documented peptides available for visceral fat and body composition support, but it’s still a prescription treatment that deserves a real medical evaluation, not a decision made from a blog post. TRT Colombia can connect you with doctor allies across our network in Colombia who can evaluate whether tesamorelin is appropriate for your goals and health history. If you’re ready to take that next step, schedule your consultation to get started, or learn more about TRT Colombia and the full range of physician-guided treatments we help coordinate.
TRT Colombia is a medical tourism facilitator that connects international clients with licensed, independent doctor allies in Colombia. TRT Colombia does not provide medical advice, diagnose conditions, or administer treatment directly. Any treatment, including tesamorelin, requires evaluation and prescription by a licensed physician.



